文献速递糖尿病肥胖与代谢综合征

标准与加长肠道旁路对2型糖尿病Roux-en-Y胃旁路术后GLP-1调节及糖代谢的影响:Long-Limb研究

The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study.
PubMed 文献 · Diabetes Care · 2020-11-06

该研究将53例肥胖2型糖尿病患者随机分为标准肢体RYGB(胆胰支50 cm)或长肢体RYGB(胆胰支150 cm),在基线、术后2周及体重减轻20%时进行混合餐试验和高胰岛素正葡萄糖钳夹。两组术后餐后GLP-1分泌均增强且血糖改善,但GLP-1峰值浓度、达峰时间、胰岛素分泌及胰岛素敏感性均无显著差异。结论:延长肠道旁路并不影响GLP-1分泌,RYGB术后GLP-1反应增强可能不依赖营养物质到达更远端肠道。

要点

  • 长肢体RYGB(150 cm胆胰支)与标准肢体(50 cm)相比,未增强餐后GLP-1分泌。
  • 两组术后餐后GLP-1分泌均较基线增强,血糖均改善。
  • 延长肠道旁路未额外改善胰岛素分泌或胰岛素敏感性。

核心结论

  • 延长RYGB肠道旁路不影响GLP-1分泌,RYGB术后GLP-1反应增强可能不依赖营养物质到达更远端肠道。

研究设计与样本

  • 随机对照机制研究,53例肥胖2型糖尿病患者随机分为标准肢体RYGB(胆胰支50 cm)或长肢体RYGB(胆胰支150 cm)。
  • 在基线、术后2周及体重减轻20%时行混合餐试验测GLP-1和胰岛素分泌,并用高胰岛素正葡萄糖钳夹测胰岛素敏感性。

主要发现

  • 两组术后餐后GLP-1分泌均较基线增强,血糖均改善。
  • 两组间餐后GLP-1峰值浓度、达峰时间、胰岛素分泌及胰岛素敏感性均无显著差异。

临床怎么用

  • 对于接受RYGB的肥胖2型糖尿病患者,延长胆胰支至150 cm并未比标准50 cm带来额外GLP-1或糖代谢获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Roux-en-Y gastric bypass (RYGB) characteristically enhances postprandial levels of glucagon-like peptide 1 (GLP-1), a mechanism that contributes to its profound glucose-lowering effects. This enhancement is thought to be triggered by bypass of food to the distal small intestine with higher densities of neuroendocrine L-cells. We hypothesized that if this is the predominant mechanism behind the enhanced secretion of GLP-1, a longer intestinal bypass would potentiate the postprandial peak in GLP-1, translating into higher insulin secretion and, thus, additional improvements in glucose tolerance. To investigate this, we conducted a mechanistic study comparing two variants of RYGB that differ in the length of intestinal bypass. RESEARCH DESIGN AND METHODS: A total of 53 patients with type 2 diabetes (T2D) and obesity were randomized to either standard limb RYGB (50-cm biliopancreatic limb) or long limb RYGB (150-cm biliopancreatic limb). They underwent measurements of GLP-1 and insulin secretion following a mixed meal and insulin sensitivity using euglycemic hyperinsulinemic clamps at baseline and 2 weeks and at 20% weight loss after surgery. RESULTS: Both groups exhibited enhancement in postprandial GLP-1 secretion and improvements in glycemia compared with baseline. There were no significant differences in postprandial peak concentrations of GLP-1, time to peak, insulin secretion, and insulin sensitivity. CONCLUSIONS: The findings of this study demonstrate that lengthening of the intestinal bypass in RYGB does not affect GLP-1 secretion. Thus, the characteristic enhancement of GLP-1 response after RYGB might not depend on delivery of nutrients to more distal intestinal segments.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Miras AD, Kamocka A, Pérez-Pevida B, et al. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study. Diabetes Care. 2020. PMID: 33158945. doi:10.2337/dc20-0762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。